
Research

Is it enough to treat the symptoms, or would we rather get to the causes of the illness? Up to now, schizophrenia has mainly been treated symptomatically, as little is known about the exact underlying processes. Researchers at the NMI Natural and Medical Sciences Institute in Reutlingen have succeeded in gaining a better understanding of […]
read more
Brain tumour cells rapidly integrate into brain-wide neuronal circuits
Researchers at the Medical Faculty of Heidelberg University and the Heidelberg University Hospital have used modified rabies viruses to label glioblastoma tumour cells and their direct cell contacts in the mouse brain. The new method showed that the tumour cells are connected to different types of nerve cells throughout the entire brain at a very […]
read more
Warm – warmer – neuronal rapid fire: How the brain gets used to heat
For the first time, researchers from the Heidelberg Medical Faculty of the Heidelberg University describe a cell-specific neuronal mechanism associated with heat tolerance in the journal Nature Neuroscience. Animals and humans develop a certain tolerance to prolonged heat: the body adjusts to release heat instead of generating it, and the metabolism and cardiovascular system adapt. […]
read more
EMBL Agri-Tech Partnership to deliver safe food and environmental health
The partnership will address global food security challenges through optimised agricultural research and data-driven innovation ByEffie Mutasa-Gottgens, Matt Hall, Birgit Kerber, Sarah Dayer, Emily Pomeroy, and Laurène Ramos Martins Feeding a growing global population while adapting to challenges posed by climate change remains one of humanity’s most pressing concerns. Worldwide, crops are under threat from […]
read more
Affimed Announces Acimtamig and AlloNK® Combination Granted Regenerative Medicine Advanced Therapy (RMAT) Designation by the U.S. Food and Drug Administration (FDA)
Designation was based on early efficacy data demonstrating an 83.3% (10/12) overall response rate and a 50% (6/12) complete response rate, with a well-managed safety profile in Relapsed/Refractory Hodgkin Lymphoma patients MANNHEIM, Germany, Dec. 05, 2024 (GLOBE NEWSWIRE) — Affimed N.V. (Nasdaq: AFMD) (“Affimed”, or the “Company”), a clinical-stage immuno-oncology company committed to giving patients […]
read more
Joint research on the next generation of sun screens
The German Cancer Research Center (DKFZ) and Beiersdorf are cooperating on the development of innovative sun protection products – and are working together to educate people about effective protection against harmful UV radiation. Experts predict that climate change and the associated increase in the number of hours of sunshine will lead to a further increase […]
read more
Innovation Prize 2025 of the German BioRegions – Application Deadline: February 14, 2025
Innovators wanted. APPLY NOW!WE SUPPORT YOUR INNOVATIVE INVENTION! The work group of the BioRegions in Germany is the central network of regional initiatives promoting the economic use of modern biotechnologies in Germany. It annually awards the Innovation Prize of the BioRegions in Germany. This year, the work group again recognizes application-oriented ideas with strong implementation […]
read more
VERAXA Biotech and Navigo Proteins Initiate Research Collaboration to Establish Pre-Targeting Strategies for Novel Affilin Radio Conjugates
The agreement brings together Navigo Protein’s Affilin® platform with VERAXA’s proprietary click chemistry platform and conjugation expertise HEIDELBERG, and HALLE, Germany, December 12, 2024 — VERAXA Biotech AG, an emerging leader in designing novel cancer therapies, and Navigo Proteins GmbH, an innovator developing next-generation targeted radiotheranostics, announced today the initiation of a research collaboration to evaluate […]
read more
EU-OPENSCREEN announces new service category: Chemoproteomics and Spatial MS-Based Omics
Three institutions have joined our consortium as official Chemoproteomics and Spatial Mass Spectrometry (MS)-Based Omics partner sites, enhancing the services we can offer to the research community in the areas of target identification and validation. Phil Gribbon, Director General of EU-OPENSCREEN, emphasised: “The three new chemoproteomics sites joining the EU-OPENSCREEN partner network provide a significant boost […]
read more